Blog / Archives
Rayno 2016 Life Science Portfolio Update…BLUE,IBB…Update-2
Update-1... See Caution 9/29 Update-2...See Rayno Biobeat for updates after Trump Rally. For overweighting biotechs in a portfolio consider XBI instead of IBB to get mid and small cap exposure....
Biotech Stocks Pause at Resistance: IBB…Update-2…Caution
Update-2... 9/29 Caution on Biotech-Major Sell-Off with IBB off 3.12% The market had a bad day today hit by Wells Fargo (WFC) Congressional hearings and paranoia about Deutsche Bank AG (DB)....
Biotech ETFs Lead Q3 Rally: XBI Breaks Out
Biotech ETFs Are Having A Strong Quarter and Offer Good Investment Options On July 20 we did a review of active funds vs biotech ETFs in the biotechnology/life science sector just after the BREXIT...
Stealth Biotech Rally With Momentum Rising…Update-1
Update-1...FED Goes on Hold with Rate Increase Likely by Year End Three on FOMC dissented wanting a rate hike this round. Market immediately rallied with NASDAQ up 1.03% at close; S&P and Dow...
Biopharma Stocks Show Resilience in Yo-Yo Week…Update-1
Biopharma Stocks Breeze through 'Quadruple Witching Day"...9/16 Healthcare stocks (XLV) were one of the leading sectors on a down day up a tiny bit to $72. The IBB held, up 0.57% to the $291 mark...
FED Fear Factor Fades then Biotechs Rally: AMGN,IBB…Update-1 Bearish Reversal
Update-1... 9/13... Hard to Call Next Move: Macro and i Rates Rule The market was rattled at the opening with the IEA news on cuts in the demand forecast for crude which dropped 2.33%. Subsequently...
Biotechs Eke Out Gains On Product Pipeline News…Update-2
Update-2...Market rallies Monday after 2% sell-off on Friday IBB held support at $280, up 1.9% today to 284 as of mid-morning . Mid-caps and large caps strong. ------ Update-1... FED Rate Increase...
Deal of the Day: Cepheid (CPHD) Sells Out to Danaher (DHR) for $4B
M&A Deal of the Day: Cepheid (CPHD) up 50% Over Friday Close on Cash Buyout We have been spending too much time on biopharma. It is time to dust off our Dx and Tools portfolio, which is on hold,...
Healthcare Stocks Lag Market on Drug Pricing…Update-2
Update-2... 945 am EDT...Biotechs Hold Support IBB up 1.55% to $285 holding support at $280; XBI up 2.99% to $61.95 holding support at $60. Update-1...More Fallout from Mylan (MYL) EpiPen Drug...
Biotech Investors Stung By Drug Pricing Flap…Update-1
Update-1... IBB Trying to hold the $280 line after media bashing of EpiPen Pricing- now they have a generic EpiPen for half the price! Biotech outflows are a concern (-$184M) Gilead Sciences (GILD)...